| S6871 |
Sodium oxamate
|
Sodium oxamate (SO, Aminooxoacetic acid, Oxamic acid) is an inhibitor of lactate dehydrogenase (LDH) that specificly inhibits LDH‑A. This compound induces G2/M cell cycle arrest via downregulation of the CDK1/cyclin B1 pathway and promotes apoptosis through enhancement of mitochondrial ROS generation.
|
-
Cell Death Discov, 2026, 12(1)146
-
Adv Sci (Weinh), 2025, 12(8):e2411943
-
Nucleic Acids Res, 2025, 53(17)gkaf882
|
|
| S0108 |
AZ-33
|
AZ-33 (LDHA Inhibitor 33) is a potent inhibitor of lactate dehydrogenase A (LDHA) with IC50 of 0.5 μM. LDHA is the key enzyme involved in anaerobic glycolysis which is frequently deregulated in human malignancies.
|
-
Frontiers in Molecular Biosciences, January 12, 2022, 806650
-
Research Square (Preprint), 2025, nan
-
Frontiers in Molecular Biosciences, 2022, 806650
|
|
| S8928 |
FX-11 (LDHA Inhibitor FX11)
|
FX-11(LDHA Inhibitor FX11) is a potent inhibitor of lactate dehydrogenase A (LDHA)) with IC50 of 49.27 μM in BxPc-3 cells.
|
-
Theranostics, 2025, 15(7):3055-3075
-
Cell Death Dis, 2025, 16(1):574
-
Cell Metab, 2024, S1550-4131(24)00415-7
|
|
| S9606 |
Galloflavin
|
Galloflavin (NSC 107022) is a novel inhibitor of lactate dehydrogenasee (LDH) with Ki values of 5.46 μM and 15.06 μM for LDH-A and LDH-B, respectively.
|
-
J Virol, 2024, 98(1):e0167023
-
Journal of Virology, 2024, e01670-23
-
Journal of Virology, 2024, e0167023
|
|
| E4772 |
LDHA-IN-3
|
LDHA-IN-3, a selenobenzene derivative, is a potent noncompetitive inhibitor of Lactate Dehydrogenase A (LDHA), with an IC50 of 145.2 nM. It exhibits significant anti-tumor activity, effectively reducing LDHA activity and lactate production under both normoxic and hypoxic conditions. It also induces mitochondria-mediated apoptosis through the generation of reactive oxygen species.
|
|
|
| E4635New |
AXKO-0046 hydrochloride
|
AXKO-0046 hydrochloride is an indole-derived, selective LDHB inhibitor that acts through an uncompetitive mechanism, with an EC50 of 42 nM. It binds an allosteric site distinct from the catalytic active site and shows selectivity over LDHA.
|
|
|
| E3731 |
Chinese Gallnut Extract
|
Chinese Gallnut Extract is obtained from Melaphis chinensis gallnut, which is the most potent inhibitor of human Lactate dehydrogenase (LDH)-A in the high-throughput screening study of 905 natural products.
|
|
|
| E6631New |
Oxamic acid
|
Oxamic acid (Oxamate) is a classical inhibitor of lactate dehydrogenase‑A (LDH‑A) that competitively blocks the conversion of pyruvate to lactate. It also induces G2/M arrest and apoptosis, and increases radiosensitivity in nasopharyngeal carcinoma cells.
|
|
|
| S6675 |
(R)-GNE-140
|
(R)-GNE-140 is an inhibitory agent for LDHA, LDHB, and LDHC, with IC50 values of 3 nM and 5 nM for LDHA and LDHB, respectively. (R)-GNE-140 is 18 times more potent than its S isomer.
|
-
J Clin Invest, 2024, 134(17)e177606
-
Nature Communications, 2024, 90
-
J Mol Cell Biol, 2024, mjae056
|
|
| S8590 |
GSK2837808A
|
GSK2837808A is a selective LDHA (lactate dehydrogenase A) inhibitor with IC50 of 2.6 nM and 43 nM for hLDHA and hLDHB, respectively.
|
-
Cancer Commun (Lond), 2025, 10.1002/cac2.70036
-
EMBO Rep, 2025, 10.1038/s44319-025-00573-8
-
Nat Neurosci, 2022, 25(7):865-875
|
|